NO20081074L - Macrocyclisk inhibitorer av hepatitis C-virus - Google Patents

Macrocyclisk inhibitorer av hepatitis C-virus

Info

Publication number: NO20081074L
Authority: NO; Norway
Prior art keywords: hepatitis; virus; inhibitors; macrocyclic inhibitors; hcv
Prior art date: 2005-07-29

Application number

NO20081074A

Other languages

English (en)

Norwegian (no)

Inventor

Herman Augustinus De Kock

Kenneth Alan Simmen

Pierre Jean-Marie Bernard Raboisson

Karl Magnus Nilsson

Bengt Bertil Samuelsson

Asa Annicka Kristin Rosenquist

Mats Stefan Lindstrom

Pia Cecilia Kahnberg

Dmitry Antonov

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-29

Filing date

2008-02-29

Publication date

2008-04-29

2008-02-29 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2008-04-29 Publication of NO20081074L publication Critical patent/NO20081074L/no

Links

239000003112 inhibitor Substances 0.000 title abstract 3
241000711549 Hepacivirus C Species 0.000 title 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
150000001204 N-oxides Chemical class 0.000 abstract 1
NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 abstract 1
229960000311 ritonavir Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20081074A 2005-07-29 2008-02-29 Macrocyclisk inhibitorer av hepatitis C-virus NO20081074L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05107066		2005-07-29
EP06101278		2006-02-03
PCT/EP2006/064812 WO2007014918A1 (en)	2005-07-29	2006-07-28	Macrocyclic inhibitors of hepatitis c virus

Publications (1)

Publication Number	Publication Date
NO20081074L true NO20081074L (no)	2008-04-29

Family

ID=37102945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081074A NO20081074L (no)	2005-07-29	2008-02-29	Macrocyclisk inhibitorer av hepatitis C-virus

Country Status (31)

Country	Link
US (1)	US8008251B2 (pt)
EP (1)	EP1913014B1 (pt)
JP (1)	JP5508713B2 (pt)
KR (1)	KR101321392B1 (pt)
CN (1)	CN101233147B (pt)
AR (1)	AR054881A1 (pt)
AT (1)	ATE496934T1 (pt)
AU (1)	AU2006274857B2 (pt)
BR (1)	BRPI0614515A2 (pt)
CA (1)	CA2616954C (pt)
CY (1)	CY1112001T1 (pt)
DE (1)	DE602006019879D1 (pt)
DK (1)	DK1913014T3 (pt)
EA (1)	EA200800485A1 (pt)
GT (1)	GT200600340A (pt)
HR (1)	HRP20110289T1 (pt)
IL (1)	IL188281A (pt)
ME (1)	ME01233B (pt)
MX (1)	MX2008001394A (pt)
MY (1)	MY139987A (pt)
NO (1)	NO20081074L (pt)
NZ (1)	NZ564542A (pt)
PE (1)	PE20070210A1 (pt)
PL (1)	PL1913014T3 (pt)
PT (1)	PT1913014E (pt)
RS (1)	RS51776B (pt)
SG (1)	SG163610A1 (pt)
SI (1)	SI1913014T1 (pt)
TW (1)	TWI437993B (pt)
UY (1)	UY29702A1 (pt)
WO (1)	WO2007014918A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY140680A (en)	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
ES2336009T3 (es)	2004-01-30	2010-04-07	Medivir Ab	Inhibidores de la ns-3 serina proteasa del vhc.
US20090074815A1 (en) *	2005-04-22	2009-03-19	Sciclone Pharmaceuticals, Inc.	Immunomodulator Compounds as Vaccine Enhancers
PE20070211A1 (es)	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
US7741281B2 (en)	2005-11-03	2010-06-22	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
WO2008008776A2 (en)	2006-07-11	2008-01-17	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
US8343477B2 (en)	2006-11-01	2013-01-01	Bristol-Myers Squibb Company	Inhibitors of hepatitis C virus
US7772180B2 (en)	2006-11-09	2010-08-10	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8003604B2 (en)	2006-11-16	2011-08-23	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7888464B2 (en)	2006-11-16	2011-02-15	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7763584B2 (en)	2006-11-16	2010-07-27	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
WO2008059046A1 (en) *	2006-11-17	2008-05-22	Tibotec Pharmaceuticals Ltd.	Macrocyclic inhibitors of hepatitis c virus
US8383583B2 (en)	2007-10-26	2013-02-26	Enanta Pharmaceuticals, Inc.	Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
US8202996B2 (en)	2007-12-21	2012-06-19	Bristol-Myers Squibb Company	Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
RU2490272C2 (ru)	2008-02-04	2013-08-20	Айденикс Фармасьютикалз, Инк.	Макроциклические ингибиторы серинпротеазы
CA2719008A1 (en)	2008-03-20	2009-09-24	Enanta Pharmaceuticals, Inc.	Fluorinated macrocyclic compounds as hepatitis c virus inhibitors
US8163921B2 (en)	2008-04-16	2012-04-24	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7964560B2 (en)	2008-05-29	2011-06-21	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
CN102046648A (zh)	2008-05-29	2011-05-04	百时美施贵宝公司	丙型肝炎病毒抑制剂
US8207341B2 (en)	2008-09-04	2012-06-26	Bristol-Myers Squibb Company	Process or synthesizing substituted isoquinolines
US8044087B2 (en)	2008-09-29	2011-10-25	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8563505B2 (en)	2008-09-29	2013-10-22	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8283310B2 (en)	2008-12-15	2012-10-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
TW201040181A (en)	2009-04-08	2010-11-16	Idenix Pharmaceuticals Inc	Macrocyclic serine protease inhibitors
AR077712A1 (es)	2009-08-05	2011-09-14	Idenix Pharmaceuticals Inc	Inhibidores de serina proteasa macrociclica
TW201309690A (zh)	2011-02-10	2013-03-01	Idenix Pharmaceuticals Inc	巨環絲胺酸蛋白酶抑制劑，其醫藥組合物及其於治療ｈｃｖ感染之用途
US8957203B2 (en)	2011-05-05	2015-02-17	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8691757B2 (en)	2011-06-15	2014-04-08	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US9207002B2 (en)	2011-10-12	2015-12-08	International Business Machines Corporation	Contaminant separator for a vapor-compression refrigeration apparatus
JP6154474B2 (ja)	2012-10-19	2017-06-28	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Ｃ型肝炎ウイルス阻害剤
US9643999B2 (en)	2012-11-02	2017-05-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
EP2914613B1 (en)	2012-11-02	2017-11-22	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
WO2014071007A1 (en)	2012-11-02	2014-05-08	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
EP2914614B1 (en)	2012-11-05	2017-08-16	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
EP2964664B1 (en)	2013-03-07	2017-01-11	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
CN117186000B (zh) *	2023-08-16	2026-06-02	上海凌凯科技股份有限公司	一种喹啉类化合物的制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69334250D1 (de)	1992-12-29	2009-01-29	Abbott Lab	Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
IL110752A (en)	1993-09-13	2000-07-26	Abbott Lab	Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en)	1993-10-01	1996-09-24	Abbott Laboratories	Pharmaceutical composition
IL111991A (en)	1994-01-28	2000-07-26	Abbott Lab	Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
US6037157A (en)	1995-06-29	2000-03-14	Abbott Laboratories	Method for improving pharmacokinetics
US6054472A (en)	1996-04-23	2000-04-25	Vertex Pharmaceuticals, Incorporated	Inhibitors of IMPDH enzyme
US5807876A (en)	1996-04-23	1998-09-15	Vertex Pharmaceuticals Incorporated	Inhibitors of IMPDH enzyme
PL192628B1 (pl)	1996-04-23	2006-11-30	Vertex Pharma	Pochodne mocznika, kompozycje farmaceutyczne i zastosowanie związku i kompozycji
NZ335276A (en)	1996-10-18	2000-09-29	Vertex Pharma	Inhibitors of serine proteases, particularly hepatitis C virus (HCV) NS3 (Non Structural Protein 3) protease
GB9623908D0 (en)	1996-11-18	1997-01-08	Hoffmann La Roche	Amino acid derivatives
ATE244717T1 (de)	1997-03-14	2003-07-15	Vertex Pharma	Inhibitoren des impdh-enzyms
PT1012180E (pt)	1997-08-11	2005-04-29	Boehringer Ingelheim Ca Ltd	Analogos de peptidos inibidores da hepatite c
US6323180B1 (en)	1998-08-10	2001-11-27	Boehringer Ingelheim (Canada) Ltd	Hepatitis C inhibitor tri-peptides
CZ301802B6 (cs)	1999-03-19	2010-06-30	Vertex Pharmaceuticals Incorporated	Deriváty mocoviny jako inhibitory IMPDH a farmaceutické prostredky s jejich obsahem
UA74546C2 (en) *	1999-04-06	2006-01-16	Boehringer Ingelheim Ca Ltd	Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
SV2003000617A (es)	2000-08-31	2003-01-13	Lilly Co Eli	Inhibidores de la proteasa peptidomimetica ref. x-14912m
US6867185B2 (en) *	2001-12-20	2005-03-15	Bristol-Myers Squibb Company	Inhibitors of hepatitis C virus
EP1497282A2 (en)	2002-04-11	2005-01-19	Vertex Pharmaceuticals Incorporated	Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease
US20050075279A1 (en) *	2002-10-25	2005-04-07	Boehringer Ingelheim International Gmbh	Macrocyclic peptides active against the hepatitis C virus
ATE422895T1 (de) *	2003-04-16	2009-03-15	Bristol Myers Squibb Co	Makrocyclische isochinolinpeptidinhibitoren des hepatitis-c-virus
US7125845B2 (en) *	2003-07-03	2006-10-24	Enanta Pharmaceuticals, Inc.	Aza-peptide macrocyclic hepatitis C serine protease inhibitors
EP1673385B1 (en) *	2003-09-22	2011-03-02	Boehringer Ingelheim International GmbH	Macrocyclic peptides active against the hepatitis c virus
ES2336009T3 (es) *	2004-01-30	2010-04-07	Medivir Ab	Inhibidores de la ns-3 serina proteasa del vhc.
PE20070211A1 (es) *	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
EP1910347A2 (en) *	2005-07-29	2008-04-16	Medivir Ab	Macrocylic inhibitors of hepatitis c virus
EP1919904B1 (en) *	2005-07-29	2014-01-08	Janssen R&D Ireland	Macrocyclic inhibitors of hepatitis c virus
AR055105A1 (es) *	2005-07-29	2007-08-08	Tibotec Pharm Ltd	Inhibidores macrociclicos del virus de la hepatitis c

2006
- 2006-07-26 PE PE2006000905A patent/PE20070210A1/es not_active Application Discontinuation
- 2006-07-28 CN CN2006800275421A patent/CN101233147B/zh not_active Expired - Fee Related
- 2006-07-28 ME MEP-2011-73A patent/ME01233B/me unknown
- 2006-07-28 EP EP06764263A patent/EP1913014B1/en not_active Expired - Lifetime
- 2006-07-28 JP JP2008523374A patent/JP5508713B2/ja not_active Expired - Fee Related
- 2006-07-28 CA CA2616954A patent/CA2616954C/en not_active Expired - Fee Related
- 2006-07-28 PT PT06764263T patent/PT1913014E/pt unknown
- 2006-07-28 MX MX2008001394A patent/MX2008001394A/es active IP Right Grant
- 2006-07-28 EA EA200800485A patent/EA200800485A1/ru unknown
- 2006-07-28 SI SI200630993T patent/SI1913014T1/sl unknown
- 2006-07-28 US US11/995,888 patent/US8008251B2/en not_active Expired - Fee Related
- 2006-07-28 UY UY29702A patent/UY29702A1/es unknown
- 2006-07-28 TW TW095127583A patent/TWI437993B/zh not_active IP Right Cessation
- 2006-07-28 AU AU2006274857A patent/AU2006274857B2/en not_active Ceased
- 2006-07-28 DK DK06764263.7T patent/DK1913014T3/da active
- 2006-07-28 WO PCT/EP2006/064812 patent/WO2007014918A1/en not_active Ceased
- 2006-07-28 AT AT06764263T patent/ATE496934T1/de active
- 2006-07-28 DE DE602006019879T patent/DE602006019879D1/de not_active Expired - Lifetime
- 2006-07-28 HR HR20110289T patent/HRP20110289T1/hr unknown
- 2006-07-28 KR KR1020087004157A patent/KR101321392B1/ko not_active Expired - Fee Related
- 2006-07-28 SG SG201005076-3A patent/SG163610A1/en unknown
- 2006-07-28 MY MYPI20063667A patent/MY139987A/en unknown
- 2006-07-28 BR BRPI0614515-9A patent/BRPI0614515A2/pt not_active IP Right Cessation
- 2006-07-28 GT GT200600340A patent/GT200600340A/es unknown
- 2006-07-28 AR ARP060103302A patent/AR054881A1/es unknown
- 2006-07-28 RS RS20110174A patent/RS51776B/sr unknown
- 2006-07-28 PL PL06764263T patent/PL1913014T3/pl unknown
- 2006-07-28 NZ NZ564542A patent/NZ564542A/en not_active IP Right Cessation
2007
- 2007-12-20 IL IL188281A patent/IL188281A/en not_active IP Right Cessation
2008
- 2008-02-29 NO NO20081074A patent/NO20081074L/no not_active Application Discontinuation
2011
- 2011-04-26 CY CY20111100415T patent/CY1112001T1/el unknown

Also Published As

Publication number	Publication date
UY29702A1 (es)	2007-05-31
WO2007014918A1 (en)	2007-02-08
PL1913014T3 (pl)	2011-06-30
AU2006274857A1 (en)	2007-02-08
SG163610A1 (en)	2010-08-30
HK1116503A1 (en)	2008-12-24
EP1913014A1 (en)	2008-04-23
BRPI0614515A2 (pt)	2011-03-29
TWI437993B (zh)	2014-05-21
IL188281A (en)	2015-01-29
HRP20110289T1 (hr)	2011-05-31
JP2009502881A (ja)	2009-01-29
IL188281A0 (en)	2008-04-13
NZ564542A (en)	2010-03-26
KR101321392B1 (ko)	2013-10-30
PT1913014E (pt)	2011-04-20
GT200600340A (es)	2007-02-26
CA2616954A1 (en)	2007-02-08
US20080200503A1 (en)	2008-08-21
CY1112001T1 (el)	2015-11-04
ATE496934T1 (de)	2011-02-15
JP5508713B2 (ja)	2014-06-04
TW200801044A (en)	2008-01-01
AR054881A1 (es)	2007-07-25
EA200800485A1 (ru)	2009-04-28
RS51776B (sr)	2011-12-31
CN101233147B (zh)	2012-06-20
EP1913014B1 (en)	2011-01-26
ME01233B (me)	2013-06-20
PE20070210A1 (es)	2007-04-16
DK1913014T3 (da)	2011-08-01
CN101233147A (zh)	2008-07-30
DE602006019879D1 (de)	2011-03-10
MX2008001394A (es)	2008-04-08
CA2616954C (en)	2013-12-24
KR20080039430A (ko)	2008-05-07
MY139987A (en)	2009-11-30
AU2006274857B2 (en)	2012-11-29
US8008251B2 (en)	2011-08-30
SI1913014T1 (sl)	2011-06-30

Legal Events

Date	Code	Title	Description
2016-02-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
SG163610A1 (en)	2010-08-30	Macrocyclic inhibitors of hepatitis c virus
NO20081073L (no)	2008-04-28	Makrocykliske inhibitorer av hepatitt C virus
NO20081071L (no)	2008-04-25	Makrocykliske inhibitorer av hepatitt C virus
EA200970493A1 (ru)	2009-10-30	Макроциклические ингибиторы вируса гепатита с
TW200745118A (en)	2007-12-16	Macrocylic inhibitors of hepatitis C virus
TW200740775A (en)	2007-11-01	Macrocylic inhibitors of hepatitis C virus
NO20066055L (no)	2007-01-24	Pyridinderivater
PE20090630A1 (es)	2009-05-16	Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion
TW200639169A (en)	2006-11-16	Bicyclic heteroaryl derivatives for treating viruses
TW200800949A (en)	2008-01-01	Macrocylic inhibitors of hepatitis C virus
NO20080879L (no)	2008-04-17	HCV-NS3-proteaseinhibitorer
NO20082496L (no)	2008-07-24	Pyrazinderivater
DK2314582T3 (da)	2014-06-10	Heterocykliske forbindelser som antivirusmidler
MXPA03005822A (es)	2004-05-04	Compuestos heterociclicos que tienen actividad antibacteriana, proceso para su preparacion y composiciones farmaceuticas que los contienen.
NO20071642L (no)	2007-06-01	N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DK1392714T3 (da)	2006-01-09	Steroider som agonister for FXR
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20091409L (no)	2009-04-07	Pyridin-3-yl-derivater som immunmodulerende midler
NO20053794L (no)	2005-08-10	N-(1-benzyl-2-oxo-2-(1-piperazinyl) etyl)-1-piperidinkarboksamid-derivater og relaterte forbindelsers bruk som CGRP-antagonister for behandling av hodepine.
NO20056010L (no)	2006-01-20	Biaryloksymetylaren-karboksylsyrer
WO2005003087A3 (en)	2005-03-17	Oxazole derivatives as antibacterial agents
ATE505462T1 (de)	2011-04-15	Neue biologischaktive molekü le
WO2007017728A3 (en)	2008-04-03	Novel heterocyclic compounds
DK1156058T3 (da)	2007-06-18	Fremgangsmåde til fremstilling af (E,Z) 3-(2-aminoethoxyimino)-androstan-6,17-dion og analoger deraf
NO20063111L (no)	2006-09-05	Fremgangsmate for fremstilling av tiazolpyrimidiner